These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38557323)

  • 21. Overview of the serologic and molecular basis of D variants with a focus on D variants in the Indian population.
    Parchure DS; Mishra GV; Kulkarni SS
    Immunohematology; 2023 Apr; 39(1):19-31. PubMed ID: 37017595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of the 'Asia type' DEL with weak D phenotype in chinese.
    Hou J; Li J; Xia Y; Zhang X; Yang J; Li M; Zhou Y
    Transfus Clin Biol; 2023 Nov; 30(4):387-392. PubMed ID: 37380099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations - Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-antigen.
    Chun S; Kim H; Yun JW; Yu H; Seo JY; Cho D
    Transfus Apher Sci; 2020 Aug; 59(4):102807. PubMed ID: 32423605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Multiplex Ligation-Dependent Probe Amplification Assay for Genotyping Major Blood Group Systems Including DEL Variants in the D-Negative Korean Population.
    Kim B; Lee ST; Kim S; Choi JR; Kim HO
    Ann Lab Med; 2018 Jan; 38(1):32-38. PubMed ID: 29071816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serologic findings of RhD alleles in Egyptians and their clinical implications.
    Hussein E; Teruya J
    Transfus Apher Sci; 2014 Oct; 51(2):184-7. PubMed ID: 25219636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardization of a multiplex assay to identify weak D types in a mixed-race Brazilian population.
    Silva TCS; Dezan MR; Cruz BR; Costa SSM; Dinardo CL; Bordin JO
    Immunohematology; 2023 Sep; 39(3):93-100. PubMed ID: 37843969
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular characterization of RhD variant phenotypes among blood donors: A study from the coastal region of India.
    Polavarapu I; Mishra G; Shastry S; Kulkarni S
    Transfus Apher Sci; 2021 Aug; 60(4):103142. PubMed ID: 33962886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of major and minor blood group antigens in the Kuwaiti Arab population.
    Ameen R; Al Shemmari S; Harris S; Teramura G; Delaney M
    Transfus Apher Sci; 2020 Aug; 59(4):102748. PubMed ID: 32527616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of Rhesus blood group antigens and weak D alleles in the population of Albania.
    Xhetani M; Seferi I; Férec C; Zoraqi G; Fichou Y
    Blood Transfus; 2014 Oct; 12(4):565-9. PubMed ID: 24960662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic RHD genotyping in Brazilians reveals a high frequency of partial D in transfused patients serologically typed as weak D.
    Miranda MR; Dos Santos TD; Castilho L
    Transfus Apher Sci; 2021 Dec; 60(6):103235. PubMed ID: 34389204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients?
    Krog GR; Clausen FB; Berkowicz A; Jørgensen L; Rieneck K; Nielsen LK; Dziegiel MH
    Transfusion; 2011 Nov; 51(11):2278-85. PubMed ID: 21569040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RHD genotyping to resolve weak and discrepant RhD patient phenotypes.
    Barriteau CM; Lindholm PF; Hartman K; Sumugod RD; Ramsey G
    Transfusion; 2022 Nov; 62(11):2194-2199. PubMed ID: 36218305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
    Credidio DC; Pellegrino J; Castilho L
    Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors.
    Gaspardi AC; Sippert EA; De Macedo MD; Pellegrino J; Costa FF; Castilho L
    Blood Transfus; 2016 Sep; 14(5):449-54. PubMed ID: 27177398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Novel
    Matzhold EM; Bemelmans M; Polin H; Körmöczi GF; Schönbacher M; Wagner T
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.
    Reid ME; Halter Hipsky C; Hue-Roye K; Hoppe C
    Blood Cells Mol Dis; 2014 Apr; 52(4):195-202. PubMed ID: 24309423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RHD Genotyping of Rh-Negative and Weak D Phenotype among Blood Donors in Southeast Iran.
    Sadeghi-Bojd Y; Amirizadeh N; Oodi A
    Int J Hematol Oncol Stem Cell Res; 2021 Oct; 15(4):213-220. PubMed ID: 35291662
    [No Abstract]   [Full Text] [Related]  

  • 38. Serological and molecular characterisation of the most prevalent weak D variants in Croatian population.
    Stanic HS; Galic ZK; Dogic V; Bingulac-Popovic J; Jukic I
    Transfus Med; 2023 Apr; 33(2):132-136. PubMed ID: 36453092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Molecular Analysis of Serologically D-Negative and Weak/Partial D Phenotype in Thai Blood Donors.
    Thongbut J; Raud L; Férec C; Promwong C; Nuchnoi P; Fichou Y
    Transfus Med Hemother; 2020 Feb; 47(1):54-60. PubMed ID: 32110194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
    Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
    Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.